Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAL 3: Panitumumab with EOX in Advanced Oesophago-gastric Cancer
NCT00824785Phase 3Terminated
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- May 2008
- Primary completion
- Feb 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of panitumumab in oesophago-gastric cancer, sponsored by Royal Marsden NHS Foundation Trust. Started May 2008; status: terminated.
02
Drugs
panitumumab
03
Conditions
oesophago-gastric cancer
Beyond the preview
Go deeper on NCT00824785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824785.